Compounds > ammonium tungsten antimonate hydroxide oxide

Page last updated: 2024-09-04

ammonium tungsten antimonate hydroxide oxide and zidovudine

ammonium tungsten antimonate hydroxide oxide has been researched along with zidovudine in 7 studies

Compound Research Comparison

Studies (ammonium tungsten antimonate hydroxide oxide)	Trials (ammonium tungsten antimonate hydroxide oxide)	Recent Studies (post-2010) (ammonium tungsten antimonate hydroxide oxide)	Studies (zidovudine)	Trials (zidovudine)	Recent Studies (post-2010) (zidovudine)
40	2	0	10,180	1,399	1,188

Protein Interaction Comparison

Protein	Taxonomy	ammonium tungsten antimonate hydroxide oxide (IC50)	zidovudine (IC50)
Thymidine kinase, cytosolic	Homo sapiens (human)		3
Reverse transcriptase/RNaseH	Human immunodeficiency virus 1		0.6633
Protease	Human immunodeficiency virus 1		0.015

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Matthes, E; Reimer, K; Rosenthal, HA; Scholz, D	1
Kaplan, JC; Sandström, EG	1
Broder, S; Yarchoan, R	1
Sandström, E	1
Weber, J	1
Marwick, C; Riesenberg, DE	1
Rada, B	1

Reviews

4 review(s) available for ammonium tungsten antimonate hydroxide oxide and zidovudine

Article	Year
Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date. Drugs, 1987, Volume: 34, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Forecasting; Foscarnet; Immunotherapy; Phosphonoacetic Acid; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1987
Progress in the development of antiviral therapy for HTLV-III-associated diseases. Important advances in oncology, 1987 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Ribavirin; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1987
Antiviral drugs for AIDS. Current status and future prospects. Drugs, 1986, Volume: 31, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Humans; Interferon Type I; Phosphonoacetic Acid; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1986
[Experimental chemotherapy of AIDS]. Casopis lekaru ceskych, 1988, May-27, Volume: 127, Issue:22 Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antimony; Antiviral Agents; Humans; Oligopeptides; Peptide T; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1988

Other Studies

3 other study(ies) available for ammonium tungsten antimonate hydroxide oxide and zidovudine

Article	Year
Effects of suramin, HPA-23 and 3'-azidothymidine triphosphate on the reverse transcriptase of bovine leukaemia virus. Acta virologica, 1989, Volume: 33, Issue:1 Topics: Animals; Antimony; Antiviral Agents; Cattle; Kinetics; Leukemia Virus, Bovine; Models, Biological; Retroviridae; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Suramin; Tungsten; Tungsten Compounds; Zidovudine	1989
AIDS: the virus, antivirals and vaccines. British journal of hospital medicine, 1987, Volume: 37, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Genes, Viral; HIV; Humans; Phosphonoacetic Acid; Suramin; Thymidine; Tungsten; Tungsten Compounds; Viral Vaccines; Virus Replication; Zidovudine	1987
Anti-AIDS agents show varying early results in vitro and in vivo. JAMA, 1985, Nov-08, Volume: 254, Issue:18 Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Deltaretrovirus; Humans; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1985